Compare Amphastar Pharmaceuticals Inc (AMPH) vs Unity Software Inc (U) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Unity Software Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $18.72 (market cap $826.08M), while Unity Software Inc trades at $30.89 (market cap $13.48B). The key difference: Unity Software Inc is far larger — about 16.3× Amphastar Pharmaceuticals Inc's market cap, and Unity Software Inc is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | U | |
|---|---|---|
Market Cap | $826.08M | $13.48B |
Sector | Health | Technology |
52-Week High | $30.81 | $49.47 |
52-Week Low | $16.87 | $17.13 |
Enterprise Value | $1.22B | $13.58B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
Unity Software (U) trades at $30.89, up 0.52% today, with a bullish technical signal and strong analyst consensus. The stock shows improving revenue trends ($1.85B in 2025) and narrowing losses, though profitability remains negative. Recent news highlights momentum in AI advertising and cost restructuring, with Q2 2026 earnings expected on August 5, 2026.
Outlook: Growth potential exists through AI integration and margin expansion, but persistent net losses and high valuation multiples pose risks. Analyst price target of $36.50 suggests 18% upside, supported by bullish sentiment, yet investors must weigh execution risks against transformative opportunities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Unity Software Inc
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.
Read more on U →
